Strides Pharma – 480
As we posted our views in our last post about the stock price moves
effected due to currency depreciation as well as technical reasons of being
defensive relating to IT and pharma. IT story was more about valuations and
while the pharma was lagging behind. It has also started performing after
continuous declines of many quarters. It has not started showing expected
profits but the technical + news factor set up are clearly in favour and stocks
ready to go up for the short term till the front line core economy stocks
remain languish due to many domestic and global reasons; just because something
has to go up as well when markets are hitting new highs, apart from 5 stocks!
So Strides Pharma net profit declined, still it is a good buy for short
term trading purpose as it is showing bottoming out formation.
We think it can go above 600 and traders can use futures and options
segment as well to trade it.
Lupin recommendation given just before a day is already in profits of
35% in call option segment.
The given views are subject to change depending
on changing market and global economic conditions. Become member to benefit
from market and individual stock moves. Become member to get alerts for buy and sell with targets.
For
best services for traders and investors in Indian stock market for multibagger
stock calls and intraday stock, nifty, stock futures, options trading calls
visit our website www.meghacapital.in
